News
Discover the latest progress in cancer research, education and clinical care delivered by the MPCCC.

MPCCC brings precision oncology and lived experience leadership to the world stage
MPCCC’s work to improve access to precision oncology and strengthen lived experience leadership was showcased at the World Cancer Congress in Hong Kong from 24–26 September 2026.
MPCCC Program Manager Lama Karroum presented Scaling access to precision oncology, sharing how the consortium transformed its Molecular Tumour Board (MTB) from a centre-based forum into a coordinated network supporting clinicians and patients across metropolitan and regional Victoria.
Central to this approach is the MPCCC Fellows Network, which embeds clinicians within partner health services to build local expertise in molecular oncology. Fellows help identify and present cases, interpret genomic findings, communicate MTB recommendations and connect patients with targeted therapies and clinical trials.
Supported by shared governance, coordinated referral processes and digital systems, the program has involved 17 Fellows across seven institutions. The presentation highlighted a 62 per cent increase in regional referrals, more than 500 complex cases referred for MTB discussion and over 400 genomic variants reviewed. Twenty per cent of patients were matched to a molecularly targeted therapy, while 6.8 per cent joined a clinical trial following their MTB report.
Lived experience leaders Mel Sheldon and Natalie Maxwell-Davis also contributed to two congress presentations through the Statewide Cancer Consumer-led Research Program: The Power of Partnership: Unlocking Transformational Change Through Lived Experience Leadership and Lead from Lived Experience: Enhancing Cancer Care.
Their contributions highlighted the importance of recognising lived experience as expertise and embedding that expertise in cancer research and care. The statewide program brings organisations together to support diverse lived experience voices and strengthen their leadership within the cancer system.
MPCCC is a proud partner in this initiative alongside Regional Trials Network Victoria, Cancer Council Victoria, VCCC Alliance, The University of Melbourne, funded by the Victorian Department of Health.
Together, these presentations shared Victorian approaches to improving cancer care with an international audience. MPCCC thanks the patients, lived experience leaders, partner organisations, clinicians and researchers who have contributed to this work.
